is an extensively researched, peer-reviewed literature review covering the pharmacological and human clinical research on COLD-fX, aka CVT-E002, a proprietary, patented fraction of saccharides from the roots of American ginseng (Panax quinquefolius), which the Canadian government has approved for use to prevent and/or treat symptoms related to colds and flu, complete with safety data, recommended dosage levels, etc.